Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionPrivate Wealth Partners, LLC
Latest Disclosed Ownership620 shares
Latest Disclosed Value $ 218,147
Private Wealth Partners, LLC reports 13.89% decrease in ownership of AMGN / Amgen Inc.

On April 28, 2026 - Private Wealth Partners, LLC filed a 13F-HR form disclosing ownership of 620 shares of Amgen Inc. (CH:AMGN) valued at $218,147 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 720 shares of Amgen Inc.. This represents a change in shares of -13.89% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F AMGEN COM 031162100 620 -100 -13.89 218 -7.23 0.0168
2026-01-27 2025-12-31 13F AMGEN COM 031162100 720 -150 -17.24 236 -4.08 0.0167
2025-11-04 2025-09-30 13F AMGEN COM 031162100 870 -66 -7.05 246 -6.13 0.0175
2025-08-01 2025-06-30 13F AMGEN COM 031162100 936 107 12.91 261 1.16 0.0204
2025-04-22 2025-03-31 13F AMGEN COM 031162100 829 829 258 0.0214
2025-02-03 2024-12-31 13F AMGEN COM 031162100 0 -2,749 -100.00 0 -100.00
2024-10-29 2024-09-30 13F AMGEN COM 031162100 2,749 1,450 111.62 886 118.52 0.0706
2024-08-08 2024-06-30 13F AMGEN COM 031162100 1,299 300 30.03 406 42.61 0.0301
2024-05-09 2024-03-31 13F AMGEN COM 031162100 999 -2,406 -70.66 284 -71.02 0.0227
2024-02-02 2023-12-31 13F AMGEN COM 031162100 3,405 15 0.44 981 7.57 0.0829
2023-11-07 2023-09-30 13F AMGEN COM 031162100 3,390 0 0.00 911 21.14 0.0871
2023-08-03 2023-06-30 13F AMGEN COM 031162100 3,390 -27 -0.79 753 -8.96 0.0692
2023-05-04 2023-03-31 13F AMGEN COM 031162100 3,417 3,417 826 0.0825
2015-01-23 2014-12-31 13F AMGEN COM 031162100 0 -3,608 -100.00 0 -100.00
2014-10-27 2014-09-30 13F AMGEN COM 031162100 3,608 -392 -9.80 507 11.18 0.1113
2014-01-27 2013-12-31 13F AMGEN COM 031162100 4,000 0 0.00 456 1.79 0.1016
2013-10-28 2013-09-30 13F AMGEN COM 031162100 4,000 0 0.00 448 13.42 0.1061
2013-07-29 2013-06-30 13F AMGEN COM 031162100 4,000 4,000 395 0.0985
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.